{
    "title": "113_hr4287",
    "content": "The \"Independent Innovator and Repurposing Act\" may extend the patent term for using biological products. The \"Extension for Regulatory Delay\" allows a 5-year extension for patents on methods using biological products, provided certain conditions are met. An application must be submitted to the Director, including details of the biological product and the patent seeking extension. The Extension for Regulatory Delay allows a 5-year extension for patents on methods using biological products. The application must include details of the biological product, the patent seeking extension, and information demonstrating the patent was issued to an independent innovator or a qualified small business with an ownership interest. Additionally, an application for commercial marketing of the biological product must have been filed under section 351(a) of the Public Health Service Act, and at least 10 years must have elapsed since the original submission of an exemption application under section 505(i) of the Federal Food, Drug, and Cosmetic Act. The Director determines patent extension eligibility based on application representations. Compliance with requirements results in extension issuance. The Director issues a certificate of extension for 5 years if requirements are met. An interim extension of up to one year can be granted if eligibility is determined before the certificate is issued. Definitions include \"biological product\" and \"Director.\" The term \"Director\" refers to the Under Secretary of Commerce for Intellectual Property and Director of the United States Patent and Trademark Office. An \"independent innovator\" is defined as a person or entity who holds a method of use patent for a biological product and is not affiliated with the holder of a marketing application approved under the Public Health Service Act. The term \"affiliated\" includes relationships of employment, control, or common ownership. The term \"qualified small business\" refers to an entity with fewer than 500 employees, not affiliated with the holder of a marketing application approved under the Public Health Service Act. This section will take effect on the enactment date and applies to unexpired patents issued before or after that date."
}